Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 2/20 | 0.35 |
| ▸ | JAK1 | P23458 | 2/20 | 0.35 |
| ▸ | TYK2 | P29597 | 2/20 | 0.35 |
| ▸ | JAK3 | P52333 | 2/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 10/20 | 0.34 |
| ▸ | P2RX2 | Q9UBL9 | 10/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | KCNJ1 | P48048 | 2/20 | 0.33 |
| ▸ | USP14 | P54578 | 1/20 | 0.32 |
| ▸ | PLK1 | P53350 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31659875 | 1.00 | JAK2 (0.35) | JAK2JAK1TYK2JAK3P2RX3 | |
| SCHEMBL31659770 | 0.85 | JAK2 (0.37) | JAK2JAK1TYK2JAK3PDE10A | |
| SCHEMBL30331871 | 0.85 | JAK2 (0.37) | JAK2JAK1TYK2JAK3PDE10A | |
| SCHEMBL25147771 | 0.85 | JAK2 (0.37) | JAK2JAK1TYK2JAK3PDE10A | |
| SCHEMBL31659482 | 0.85 | JAK2 (0.38) | JAK2JAK1TYK2JAK3P2RX3 | |
| SCHEMBL25148210 | 0.85 | JAK2 (0.38) | JAK2JAK1TYK2JAK3P2RX3 | |
| SCHEMBL25148356 | 0.84 | P2RX3 (0.32) | P2RX3P2RX2PDE10APLK1 | |
| SCHEMBL31660328 | 0.84 | P2RX3 (0.32) | P2RX3P2RX2PDE10APLK1 | |
| SCHEMBL25148376 | 0.83 | SCN10A (0.39) | JAK2JAK1TYK2JAK3P2RX3 | |
| SCHEMBL30332227 | 0.83 | SCN10A (0.39) | JAK2JAK1TYK2JAK3P2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023064585-A1 | 7,8-DIHYDRO-5H-1,6-NAPHTHYRIDINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS | VANDERBILT UNIVERSITY (US) | 2023-04-20 | — | — | WO | disclosed |